Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07433764

Test-Retest Reliability of the WB6Dim Digital Well-Being Tool: A 3-Day Interval Study

Psychometric Validation of Test-Retest Reliability of the WB6Dim Digital Self-Assessment Tool for Well-Being Using a 3-Day Interval Protocol and Contamination Control

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Clover Link · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to establish the test-retest reliability of the WB6Dim digital self-assessment tool across its eight well-being dimensions, using a 3-day interval protocol designed to minimize the probability of genuine well-being changes between assessments. Participants complete the 28-item WB6Dim questionnaire at baseline (T1) and again 3 days later (T2). A single contamination control question at T2 identifies participants who experienced a significant life event during the interval; these pairs are excluded from primary ICC analyses and retained for exploratory analyses. An optional third assessment at 9 weeks (T3) provides preliminary exploratory data on sensitivity to change following access to a well-being program. T3 is not part of the primary design.

Detailed description

The first validation study of the WB6Dim instrument (NCT07301879) established strong internal consistency and convergent validity across N=295 participants. Test-retest reliability was assessed over a 14-day interval on N=92 usable pairs, yielding preliminary ICC estimates ranging from .49 to .77. However, the 14-day interval is methodologically suboptimal for a dynamic monitoring tool: real-life events occurring during two weeks cannot be distinguished from instrument instability, and confidence intervals were wide due to the limited number of pairs. The present study addresses these limitations through three improvements. First, the interval is reduced to 3 days, substantially reducing contamination risk while avoiding memory-based response bias. Second, a contamination control question is administered at T2 to identify and exclude pairs where a significant life event occurred. Third, the target of N=220 usable pairs produces 95% confidence intervals with maximum width of .20 across all dimensions, meeting the precision threshold for definitive psychometric publication. Only the 28 WB6Dim items are administered, with no additional gold-standard scales, reducing response burden to approximately 3 minutes per session. Participant matching is performed via email address.

Conditions

Timeline

Start date
2026-02-19
Primary completion
2026-02-22
Completion
2026-05-09
First posted
2026-02-25
Last updated
2026-02-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07433764. Inclusion in this directory is not an endorsement.